Amendments to Optometry Act allow Canadian optometrists to prescribe medication

Article

The Optometry Amendment Act will allow optometrists to prescribe and administer drugs to persons with certain eye conditions.

 

Winnipeg, Manitoba-The Optometry Amendment Act, scheduled to take effect July 15, will allow optometrists to prescribe and administer drugs to persons with certain eye conditions, said Theresa Oswald, Health Minister of Manitoba.

“Until now, optometrists treating patients requiring medication had to refer them to ophthalmologists or other physicians,” Oswald said. “The amendments will improve access to eye care and reduce wait times for treatment for patients.”

Under the new legislation, qualified optometrists will be able to prescribe and administer certain drugs to treat eye infections, glaucoma, uveitis, dry eye, and ocular allergies. Additionally, qualified optometrists will be able to collaborate with ophthalmologists to treat more serious eye diseases.

The amendments will also expand the scope of practice of optometrists so they may remove superficial foreign bodies from the eye, and order and receive screening and diagnostic tests. The change has the support of the Manitoba Association of Optometrists  (MAO).

“This is great news for our patients and everyone in Manitoba,” said Neil Campbell, OD, MAO president. “Most of our members have been educated and trained to prescribe medications for years. We are pleased that the Manitoba government has made changes that will broaden access to medically necessary services across the province.”

Optometrists provide approximately 80% of all first contact, primary vision, and eye health examinations in Manitoba, according to the MAO.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Nora Lee Cothran, OD, FAAO, moderated an Innovation Hub panel that featured 3 companies, giving insights into what's to come in the optometric industry.
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Selina McGee, OD, FAAO, Dipl ABO, shares key takeaways and a personal anecdote relating to the State of Dry Eye survey results.
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO.
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.